Andre Machado, MD, PhD and Imad Najm, MD, discuss a first-of-kind study aimed at identifying biomarkers and targets for preventing and curing neurodegenerative disorders and other neurologic diseases.
For information about claiming CE credits, go to clevelandclinic.org/neuropodcast and click on the episode.
